Campus Image

Navigation for This Section: Center for Integration of Research on Genetics and Ethics

Dean Hamer: Impact of Behavior Genetics on Medicine and Society

Abstract: Understanding the role of genes in human behavior will impact both medicine and society, but not always in the manner expected. Knowledge about behavioral genes can be used for the good, for example by improving psychiatric diagnoses, developing new drugs to treat mental illnesses, and dispelling harmful myths about certain types of human variation. However, the same sort of information could be used to discriminate against people, to provide quick fixes for social problems, or to support eugenics. How we use the new knowledge about molecular behavior genetics will depend on the legal, ethical and social policies that we develop.

Click to play video

About Dr. Hamer

Senior Principal Investigator, Laboratory of Biochemistry, NCI/DDR/NIH

Dean Hamer was born in Montclair, NJ. He received his B.A. from Trinity College, Connecticut and his Ph.D. from Harvard Medical School. He has worked at the National Institutes of Health for 28 years, where he is currently the Chief of the Section on Gene Structure and Regulation in the Laboratory of Biochemistry of the National Cancer Institute.

Dr. Hamer's research has led to major contributions in a variety of areas including recombinant DNA, drug and vaccine production, and gene regulation. He is best known for his research on the role of inheritance in human behavior, personality traits and other complex characteristics. His discovery of genetic links to sexual orientation and personality traits have changed the way we think about human behavior and raise a host of important scientific, social and ethical issues. His current research focuses on HIV/AIDS treatment and prevention.

Dr. Hamer has published over 100 scientific papers and received numerous honors including the Ariens Kappers Award for Neurobiology. His books The Science of Desire, Living With Our Genes, and The God Gene have won widespread critical acclaim.